|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental Studies |
1 From the Department of Radiology-MRI, Bolwell B 124, University Hospitals of Cleveland, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH 44106 (F.K.W., M.W., J.S.L.); Department of Radiology, Benjamin Franklin University Hospital, Free University, Berlin, Germany (F.K.W., K.R., K.J.W.); Schering, Berlin, Germany (W.E.); and Siemens, Erlangen, Germany (M.W.). From the 2000 RSNA scientific assembly. Received November 12, 2001; revision requested January 28, 2002; final revision received May 1; accepted June 5. Supported by grants R33 CA88144-01 and R01 CA81431-02 from the National Cancer Institute and grants from Siemens Medical Solutions. Address correspondence to F.K.W. (e-mail: wackerfrank@web.de).
PURPOSE: To evaluate the feasibility of using the ultrasmall superparamagnetic iron oxide (USPIO) SH U 555 C as an intravascular contrast agent for magnetic resonance (MR) imageguided vascular procedures with an open MR imaging system.
MATERIALS AND METHODS: All experiments were performed with MR imaging at 0.2 T. MR imageguided interventions were performed in USPIO-enhanced vessels in four pigs. With near real-time MR image guidance (acquisition time, 0.64 second per section), the splenic and renal arteries were consecutively catheterized by using a susceptibility artifactbased catheterguide wire combination. Angioplasty and stent implantation were performed four times in the renal artery and twice in the iliac artery. Intraaortal signal intensity (SI) was measured during the interventions.
RESULTS: After administration of SH U 555 C (40 µmol of iron per kilogram of body weight), a three-dimensional MR angiographic sequence was performed that allowed visualization of the abdominal and pelvic vessels that were as small as 2 mm in diameter. Catheterization, angioplasty, and stent implantation were successfully guided in the USPIO-enhanced vasculature. Sixty minutes after contrast agent injection, the mean aortic SI was 70% of the maximum measured enhancement levels.
CONCLUSION: One intravenous injection of SH U 555 C enabled long, continuous intravascular SI enhancement at MR angiography, and, in combination with susceptibility artifactbased device tracking, the injection allowed the performance of MR imagingguided intravascular interventions in an open MR imaging system.
© RSNA, 2003
Index terms: Animals Interventional procedures, experimental studies, 954.1268, 961.1268, 988.1268 Magnetic resonance (MR), contrast media, 954.129412, 954.12943, 961.129412, 961.12943, 988.129412, 988.12943 Magnetic resonance (MR), vascular studies, 954.129412, 954.12943, 961.129412, 961.12943, 988.129412, 988.12943 Stents and prostheses, 961.1286
This article has been cited by other articles:
![]() |
J. J. Krueger, P. Ewert, S. Yilmaz, D. Gelernter, B. Peters, K. Pietzner, A. Bornstedt, B. Schnackenburg, H. Abdul-Khaliq, E. Fleck, et al. Magnetic Resonance Imaging-Guided Balloon Angioplasty of Coarctation of the Aorta: A Pilot Study Circulation, February 28, 2006; 113(8): 1093 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Omary, J. A. Gehl, B. E. Schirf, J. D. Green, B. Lu, F. S. Pereles, J. Huang, A. C. Larson, and D. Li MR Imaging- versus Conventional X-ray Fluoroscopy-guided Renal Angioplasty in Swine: Prospective Randomized Comparison Radiology, February 1, 2006; 238(2): 489 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Wacker, D. Elgort, C. M. Hillenbrand, J. L. Duerk, and J. S. Lewin The Catheter-Driven MRI Scanner: A New Approach to Intravascular Catheter Tracking and Imaging-Parameter Adjustment for Interventional MRI Am. J. Roentgenol., August 1, 2004; 183(2): 391 - 395. [Abstract] [Full Text] [PDF] |
||||